FDA Inspection 1200173 — LXR Biotech
The FDA completed an inspection of LXR Biotech on Feb 15, 2023 in Rochester Hills, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 15, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Rochester Hills, MI (United States)